-

GE HealthCare announces digital integration between bkActiv™ intraoperative ultrasound system and Medtronic Stealth AXiS™ surgical navigation system

  • bkActiv provides real-time visualization and now offers digital integration with the Stealth AXiS surgical navigation system, together bringing planning, navigation and robotics into a unified workflow
  • Digital integration designed to help neurosurgeons assess anatomy in real-time and support surgical precision and clinical confidence
  • Collaboration builds on existing strategic alliance between GE HealthCare and Medtronic to accelerate next-generation technology innovation across the enterprise

CHICAGO--(BUSINESS WIRE)--GE HealthCare today announced a digital integration between the GE HealthCare bkActiv™ intraoperative ultrasound (iUS) system and the Medtronic Stealth AXiS™ surgical navigation system, which is now commercially available to provide real-time advanced imaging during cranial procedures to complement surgical planning and navigation workflows. This integration builds on an existing strategic alliance between the companies to accelerate next-generation technology innovation across the enterprise, which extends the relationship between GE HealthCare’s Surgical Innovations and Medtronic.

Through this new digital integration, neurosurgeons will be able to incorporate bkActiv as a “plug-and-play” real-time visualization solution during procedures using the Stealth AXiS surgical navigation system without disrupting established workflows. The Stealth AXiS surgical navigation system was recently cleared by the U.S. Food and Drug Administration (FDA) for cranial procedures in the United States, and brings planning, navigation and robotics together into a single, integrated solution to deliver real-time insight in the operating room.

“Real-time visualization is critical for cranial surgical teams to assess anatomy, navigate changes, and make critical decisions in the surgical suite,” said Heidi Seerden, General Manager, Surgical Innovations, GE HealthCare. “We are proud to build on our long-time collaboration with Medtronic to bring together bkActiv with the Stealth AXiS surgical navigation system in a way that supports our shared goals of supporting surgical precision and clinician confidence.”

During cranial procedures, surgeons may encounter “brain shift”- a natural movement or deformation of the brain during surgery that reduces the accuracy of pre-surgical images during the procedure. bkActiv is designed to provide real time visualization that may help clinicians assess anatomy changes such as brain shift by supplying the live iUS image to the Stealth AXiS surgical navigation system, where it can be viewed alongside pre-operative MRI or CT images.

bkActiv also includes features and dedicated software exam types to support visualization and workflow in the neurosurgical suite, including:

  • Image mirror feature that duplicates the ultrasound image on the scanner’s glass user interface, so surgical staff can see the ultrasound image when the clinical display monitor is turned toward the surgeon
  • Sensitive color Doppler to visualize blood flow during surgeries
  • Specialized algorithms to support uniform image resolution and detail around areas of interest
  • Fully immersible transducers for easy sterilization and single-use needle guides
  • Transducer Smart Button™ technology that allows the surgeon to freeze, store and print images with one press
  • A sterilizable remote control that enables the surgeon to control the bkActiv scanner from the sterile field

GE HealthCare and Medtronic plan to debut this digital integration at the American Association of Neurological Surgeons (AANS) Annual Scientific Meeting, May 1–4, 2026, in San Antonio, Texas. For more information on bkActiv, visit: https://www.gehealthcare.com/products/ultrasound/surgical-visualization-and-guidance/bkactiv.

About GE HealthCare Technologies Inc.

GE HealthCare is a leading global healthcare solutions provider of advanced medical technology, pharmaceutical diagnostics, and AI, cloud and software solutions that help clinicians tackle the world’s most complex diseases. Serving patients and providers for 130 years, GE HealthCare is delivering bold innovations designed for the next era of medicine across its Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics segments to help clinicians deliver more personalized, precise patient care. We are a $20.6 billion business with approximately 54,000 colleagues working to create a world where healthcare has no limits.

GE HealthCare is proud to be among 2026 Fortune World’s Most Admired Companies™.

Follow us on LinkedIn, Facebook, Instagram, or visit our website for our latest news and perspectives.

Contacts

GE HealthCare Media Contact:
Eric Tatro
M +1 312 459 6140
eric.tatro@gehealthcare.com

GE HealthCare

NASDAQ:GEHC

Release Versions

Contacts

GE HealthCare Media Contact:
Eric Tatro
M +1 312 459 6140
eric.tatro@gehealthcare.com

More News From GE HealthCare

GE HealthCare to announce first quarter 2026 results on April 29, 2026

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) will announce its first quarter 2026 financial results before the market opens on Wednesday, April 29, 2026. The GE HealthCare management team will also host a conference call and webcast at 8:30 a.m. Eastern Time / 7:30 a.m. Central Time on that same day, which will be a live webcast and accessible at https://investor.gehealthcare.com/news-events/events. The earnings release, accompanying financial information, and webcast replay also will...

GE HealthCare Recommends Shareholders Reject “Mini-Tender” Offer by Potemkin Limited

CHICAGO--(BUSINESS WIRE)--GE HealthCare Technologies Inc. (Nasdaq: GEHC) (the “Company” or “GE HealthCare”) announced today that it received notice on March 30, 2026, of an unsolicited “mini-tender” offer by Potemkin Limited to purchase up to 100,000 shares of GE HealthCare common stock at a price of $45.80 per share in cash. Potemkin Limited’s offer price of $45.80 per share is approximately 34.80 percent lower than the $70.25 closing per share price of GE HealthCare’s common stock on March 18...

GE HealthCare announces lead industrial role in largest EU-funded IHI consortium to advance cardio-oncology care across Europe

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced its leading industrial role in the new COMPASS consortium, a five-year initiative focused on improving precision cardio-oncology care and advancing early detection of cardiovascular risks in cancer patients across Europe. COMPASS combines clinical excellence with novel healthcare technology, and with a total budget of €50.5 million and more than sixty partners, it is one of the largest public-private partnerships under the I...
Back to Newsroom